Joseph Truluck is Chief Financial Officer of ADIAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 265,139 shares of ADIL, which is worth approximately $283,698. The most recent transaction as insider was on May 23, 2023, when has been sold 157,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 265K
0% 3M change
0% 12M change
Total Value Held $283,698

Joseph Truluck Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2023
BUY
Grant, award, or other acquisition
-
157,500 Added 37.27%
265,139 Common Stock
JT

Joseph Truluck

Chief Financial Officer
Charlottesville,, VA

Track Institutional and Insider Activities on ADIL

Follow ADIAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADIL shares.

Notify only if

Insider Trading

Get notified when an Adial Pharmaceuticals, Inc. insider buys or sells ADIL shares.

Notify only if

News

Receive news related to ADIAL PHARMACEUTICALS, INC.

Track Activities on ADIL